Personalized medicine in genetic epilepsies – possibilities, challenges, and new frontiers
Authors:
- 1 August 2020
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 172, 107970
Abstract
No abstract availableKeywords
Funding Information
- NIH
- National Research Service Award (NRSA) Institutional Research Training (T32 NS091008)
- Epilepsy NeuroGenetics Initiative
- German Research Foundation (HE5415/3-1)
- European Science Foundation
- German Research Foundation (DFG, HE5415/5-1, HE5415/6-1)
- DFG (He5415/7-1)
- National Institute for Neurological Disorders and Stroke (U54 NS108874)
This publication has 86 references indexed in Scilit:
- De novo mutations in epileptic encephalopathiesNature, 2013
- Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikesNature Genetics, 2013
- Successful use of fenfluramine as an add‐on treatment for Dravet syndromeEpilepsia, 2012
- PRRT2 Mutations Cause Benign Familial Infantile Epilepsy and Infantile Convulsions with Choreoathetosis SyndromeThe American Journal of Human Genetics, 2012
- A BFIS‐like syndrome with late onset and febrile seizures: Suggestive linkage to chromosome 16p11.2–16q12.1Epilepsia, 2008
- The Human Phenotype Ontology: A Tool for Annotating and Analyzing Human Hereditary DiseaseThe American Journal of Human Genetics, 2008
- Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1Brain, 2008
- GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leakJournal of Clinical Investigation, 2008
- Pyridoxal 5′‐phosphate may be curative in early‐onset epileptic encephalopathyJournal of Inherited Metabolic Disease, 2006
- Linkage Analysis and Disease Models in Benign Familial Infantile Seizures: A Study of 16 FamiliesEpilepsia, 2006